Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Dr Reddys Laboratories (RDY) over the last 8 years, with Q3 2025 value amounting to -$22.2 million.

  • Dr Reddys Laboratories' Treasury Shares fell 10322.83% to -$22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 10322.83%. This contributed to the annual value of $27.0 million for FY2025, which is 12500.0% up from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Treasury Shares of -$22.2 million as of Q3 2025, which was down 10322.83% from -$26.1 million recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Treasury Shares peaked at $27.0 million during Q1 2021, and registered a low of -$26.1 million during Q1 2025.
  • Moreover, its 5-year median value for Treasury Shares was -$11.6 million (2023), whereas its average is -$3.8 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 9426.96% in 2021, then plummeted by 31909.3% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Treasury Shares (Quarter) stood at -$22.4 million in 2021, then grew by 14.17% to -$19.2 million in 2022, then soared by 35.77% to -$12.4 million in 2023, then grew by 11.55% to -$10.9 million in 2024, then plummeted by 103.23% to -$22.2 million in 2025.
  • Its Treasury Shares stands at -$22.2 million for Q3 2025, versus -$26.1 million for Q1 2025 and -$10.9 million for Q3 2024.